Higher highs and higher lows over several sessions; significant lower shadows on several candlesticks. Oscillators reaching upwards.
Despite failure at drug trials, stock still ranked "strong buy" by TipRank's 60th best rated analyst and others. May be a an opportunity to buy Call LEAP
Coming from historical support with oscillators and buying spiking upward sharply.
Following a long lower shadow. Coming off historical support
Coming after a 7-month support and succeeding a heavy selling session yesterday with upbeat buying and an RSI pointing almost straight up. Stock hit oversold territory January 10.
Representing exact point of EMA 8 and EMA 21 crossing downwards (clearly) since the upward crossing on September 14, 2017.
With significant long upper shadows over several sessions. Confirmation from, EMA, RSI and MACD
Oscillators down; Down from historic high point
Oscillators down; selling up. Down from 9-month resistance
Early signs of steep slipping of oscillators; dipping from 12-month resistance
Sliding oscillators from historic resistance
One of most advanced stocks today. Oscillators spiking, massive buys from historic support